Low-frequency rTMS inhibits the anti-depressive effect of ECT. A pilot study

Area of Science:

• Neuroscience
• Psychiatry
• Neuromodulation

Background:

• Repetitive transcranial magnetic stimulation (rTMS) of the prefrontal cortex shows antidepressant effects.
• Electroconvulsive therapy (ECT) is an effective treatment for major depression.

Purpose of the Study:

• To investigate if right prefrontal low-frequency rTMS enhances ECT's antidepressant effects.
• To determine if rTMS reduces cognitive side effects associated with ECT.

Main Methods:

• A randomized, controlled, double-blind pilot study involving 35 patients with major depression.
• Participants received either ECT + placebo or ECT + low-frequency right prefrontal rTMS.
• Depression severity (Hamilton scale, MDI) and cognitive function were assessed.

Main Results:

• No significant difference in antidepressant response between ECT+placebo and ECT+rTMS groups.
• A trend towards lower MDI scores post-treatment in the placebo group.
• ECT's cognitive impact was transient; logical memory improved 4 weeks post-treatment.
• The ECT-rTMS group showed generally less cognitive impairment than the ECT-placebo group.

Conclusions:

• Low-frequency rTMS as an add-on to ECT did not accelerate antidepressant response.
• Results suggest low-frequency rTMS may potentially inhibit the antidepressant effect of ECT.
• Further research is needed to clarify the interaction between rTMS and ECT.